Defining the prion domain of PrP
定义 PrP 的朊病毒结构域
基本信息
- 批准号:6870268
- 负责人:
- 金额:$ 34.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-03-15 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresisclinical researchconfocal scanning microscopyfluorescence resonance energy transfergenetically modified animalshuman tissuelaboratory mouseneural degenerationpostmortemposttranslational modificationsprionsprotein sequenceprotein structure functionspongiform encephalopathytissue /cell culture
项目摘要
DESCRIPTION (provided by applicant): The prion diseases are a family of transmissible neurodegenerative disorders that affect humans and animals. A large body of evidence argues that a post-translational, non-covalent modification of the prion protein (PrP) is the fundamental event in the mechanism underlying these diseases. The normal cellular isoform (PrPC) is misfolded to the beta-sheet rich pathogenic isoform (PrPSc). Once formed, PrPSc appears to act as a conformational template to convert additional PrPC to PrPSc. Considerable evidence supports sequence homology within the central region of PrP as a necessary feature in the association of PrPSc with PrPC as a prelude to conversion and propagation of PrPSc, but the exact segment(s) involved and the sequence determinants for this conversion are unknown. Studies targeted at understanding the site(s) of association of PrPC and PrPSc will no doubt define ways to inhibit their interaction and provide treatment for these currently untreatable diseases. The proposed studies are designed, therefore, to define the molecular determinants within PrP, and primarily within the putative priori domain, that are required for efficient self-association and conformational transfer. We will primarily utilize transgenic mice that express polymorphic PrP genes to act as hosts for a variety of sporadic and genetic human prion diseases to determine if and where homologous regions and residues are required for efficient transmission of prion strain. In addition a novel yeast-based model of prion disease will be extensively utilized to study the effect of specific substitutions or deletions at potentially critical association sites of PrP on the development of PrPSC-like protein. This powerful model is not only capable of generating prpSC-Iike protein, but can support the de novo generation of at least two strains of PrPSc so, and demonstrate conformational transference of PrPSc to PrPC. The information gained from these studies will then be applied to the development of novel peptide inhibitors that are designed to bind to critical sites within the defined "prion domain" and halt additional binding of PrP. With the continued threat of bovine spongiform encephalopathy in Europe, and the current spread of chronic wasting disease of deer and elk in the U.S., these studies are urgently needed.
描述(申请人提供):Pron病是一种影响人类和动物的遗传性神经退行性疾病家族。大量证据表明,蛋白质的翻译后非共价修饰(PrP)是导致这些疾病的机制中的基本事件。正常细胞亚型(PrPC)被错误折叠为富含β-折叠的致病亚型(PrPSc)。一旦形成,PrPSc看起来就像一个构象模板,将额外的PrPC转化为PrPSc。相当多的证据支持PrP中心区的序列同源性是PrPSc与PrPC结合的必要特征,这是PrPSc转换和繁殖的前奏,但所涉及的确切片段(S)和这种转换的序列决定因素尚不清楚。旨在了解PrPC和PrPSc结合部位(S)的研究无疑将确定抑制它们相互作用的方法,并为这些目前无法治疗的疾病提供治疗。因此,拟议的研究旨在定义PrP中的分子决定因素,主要是在假定的先验结构域中,这些决定因素是有效的自结合和构象转移所必需的。我们将主要利用表达多态PrP基因的转基因小鼠作为各种散发性和遗传性人类普恩疾病的宿主,以确定是否以及在哪里需要同源区域和残基来有效传播普恩病毒株。此外,一种新的基于酵母的PrP疾病模型将被广泛用于研究PrP潜在关键结合位点的特定替换或缺失对PrPSC样蛋白发展的影响。这个强大的模型不仅能够产生PrpSC样蛋白,而且可以支持至少两株PrPSc SO的从头产生,并证明PrPSc向PrPC的构象转移。然后,从这些研究中获得的信息将被应用于新型多肽抑制剂的开发,这些多肽抑制剂被设计成与已定义的“Pron结构域”内的关键位点结合,并阻止PrP的额外结合。随着牛海绵状脑病在欧洲的持续威胁,以及目前美国鹿和麋鹿慢性消耗性疾病的传播,这些研究是迫切需要的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES A MASTRIANNI其他文献
JAMES A MASTRIANNI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES A MASTRIANNI', 18)}}的其他基金
Allele-Specific RNAi to treat Genetic Prion Disease - Resubmission 01
等位基因特异性 RNAi 治疗遗传性朊病毒病 - 重新提交 01
- 批准号:
8544512 - 财政年份:2012
- 资助金额:
$ 34.9万 - 项目类别:
Allele-Specific RNAi to treat Genetic Prion Disease - Resubmission 01
等位基因特异性 RNAi 治疗遗传性朊病毒病 - 重新提交 01
- 批准号:
8445972 - 财政年份:2012
- 资助金额:
$ 34.9万 - 项目类别:
Role of the Lysosome in ER Associated Degradation of PrP
溶酶体在 ER 相关 PrP 降解中的作用
- 批准号:
7034282 - 财政年份:2005
- 资助金额:
$ 34.9万 - 项目类别:
Role of the Lysosome in ER Associated Degradation of PrP
溶酶体在 ER 相关 PrP 降解中的作用
- 批准号:
7560376 - 财政年份:2005
- 资助金额:
$ 34.9万 - 项目类别:
Role of the Lysosome in ER Associated Degradation of PrP
溶酶体在 ER 相关 PrP 降解中的作用
- 批准号:
7153538 - 财政年份:2005
- 资助金额:
$ 34.9万 - 项目类别:
Role of the Lysosome in ER Associated Degradation of PrP
溶酶体在 ER 相关 PrP 降解中的作用
- 批准号:
7740784 - 财政年份:2005
- 资助金额:
$ 34.9万 - 项目类别:
Role of the Lysosome in ER Associated Degradation of PrP
溶酶体在 ER 相关 PrP 降解中的作用
- 批准号:
7341710 - 财政年份:2005
- 资助金额:
$ 34.9万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 34.9万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 34.9万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 34.9万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 34.9万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 34.9万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 34.9万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 34.9万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 34.9万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 34.9万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 34.9万 - 项目类别:














{{item.name}}会员




